The Associations Between Gut Length, Gut Microbiota and Food Assimilation
Associations Between Gut Length, Gut Microbiota and Food Assimilation Efficiency of Healthy Individuals
1 other identifier
observational
42
1 country
1
Brief Summary
The purpose of this observational study is to explore the relationships between gut length, the microbiota and food energy assimilation rates in humans.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 17, 2024
CompletedFirst Posted
Study publicly available on registry
April 22, 2024
CompletedStudy Start
First participant enrolled
May 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedJanuary 22, 2026
January 1, 2026
1 year
April 17, 2024
January 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Gut length
Volunteers will be scanned Magnetic Resonance Imaging(Shanghai united imaging, uMR 790).
Through study completion for one year, will be measured on arrival.
Energy intake
Response on standard feeding table, the food consumption will be recorded continuously by balances underneath each food dish. The total energy intake will be calculated in KJ (kilojoule).
Through study completion for one year, will be measured on arrival.
Fecal energy
Measuring the heat produced by burning dried feces using an oxygen bomb calorimeter (Parr6400). The total energy per gram tissue will be calculated in kJ (kilojoule)/g.
Through study completion for one year, will be measured on arrival
Microbiome/Microbiota
Abundance of gut microbiome will be from Metagenomic profiling of feces by Illumina.
Through study completion for one year, will be measured on arrival.
Metabolites
Abundance of metabolites will be from metabolomic profiling of feces by LC-MS (liquid chromatography mass spectrometry).
Through study completion for one year, will be measured on arrival.
Secondary Outcomes (20)
Urine energy content
Through study completion for one year, will be measured on arrival.
Body weight
Through study completion for one year, will be measured on arrival.
Waist circumferences
Through study completion for one year, will be measured on arrival.
Height
Through study completion for one year, will be measured on arrival.
Bone mass
Through study completion for one year, will be measured on arrival.
- +15 more secondary outcomes
Study Arms (1)
Age between 18-40 years old, 100subjects(50 female and 50 man)
He Shuang(Polyethylene Glycol Electrolytes Powder):1/1.5 sachets of PEG(68.56-102.84g dissolved in water with1/1.5L ) were provided to volunteers based on body weight(BW): BW\<60 kg, 1 sachet , BW≥60 kg, 1.5 sachets, drinking an average of 200/250 mL every 15 minutes. It will cause frequent bowel motions or diarrhoea for a couple of hours afterwards. Raceanisodamine Hydrochloride Injection: intramuscular injection of Raceanisodamine Hydrochloride Injection with 10mg. It may cause dry mouth, red face and blurred vision. The half-life of the medicine is 40 minutes and most of the above symptoms disappear within 1 to 3 hours.
Interventions
Observation of gut length, food intake, fecal and urine calories, body composition, microbiota, metabolic rate, metabolomics.
Eligibility Criteria
100 individuals, 50 female and 50 male
You may qualify if:
- Age between 18-40 years old, healthy and disease free.
- Regular bowel movements.
You may not qualify if:
- Individuals who are constipated or suffer from intestinal disorders;
- Individuals with mental illnesses such as depression and claustrophobia;
- Individuals with glaucoma and prostate hypertrophy;
- Metal implants in the body;
- Pregnant and lactating women;
- Individuals with blood phobia, pathologic hypotension or hypertension;
- Use of antibiotics, probiotics, oral laxatives within 8 weeks;
- Individuals with metabolic diseases (e.g., chronic diseases such as diabetes mellitus); recent weight loss due to various medical reasons;
- Individuals with infectious diseases (e.g. HIV);
- Irregular diet, lifestyle, addiction to tobacco, alcohol or drugs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shenzhen Institute of Advanced Technology
Shenzhen, Guangdong, 518055, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
John R Speakman, PhD
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, chief researcher
Study Record Dates
First Submitted
April 17, 2024
First Posted
April 22, 2024
Study Start
May 15, 2024
Primary Completion
June 1, 2025
Study Completion
June 30, 2025
Last Updated
January 22, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share